The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance

Molecular and Cellular Endocrinology

Volumn 393, Issue 1-2, 2014, Pages 30-38

  Cao, Xi ^a,b   Yang, Fang Yuan ^a,b   Xin, Zhong ^a,b   Xie, Rong Rong ^a,b   Yang, Jin Kui ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Key Laboratory of Diabetes Research and Care   (China)

Author keywords

ACE2; Angiotensin (1 7); Insulin resistance; Mas; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; GLUCOSE; GLUCOSE TRANSPORTER; GLYCOGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN MAS AXIS; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANGIOTENSIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRESS; ENZYME ACTIVATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL CULTURE; FLOW CYTOMETRY; GENETICS; HEPG2 CELL LINE; METABOLISM; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSINS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; HEP G2 CELLS; HUMANS; INSULIN RESISTANCE; MAP KINASE KINASE 4; MICE; MODELS, BIOLOGICAL; PEPTIDYL-DIPEPTIDASE A; RATS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84903376638     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.05.024     Document Type: Article

References (37)

1. Basu R., et al. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 2005, 54(7):1942-1948.
2. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87(1):245-313.
3. Benson S.C., et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004, 43(5):993-1002.
4. Bilman V., et al. Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7). Peptides 2012, 37(2):247-251.
5. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 2005, 7(11-12):1553-1567.
6. Clarke N.E., Turner A.J. Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 2012:307315.
7. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13(22):2905-2927.
8. Delbosc S., et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005, 179(1):43-49.
9. Evans J.L., et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 2003, 52(1):1-8.
10. Giani J.F., et al. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am. J. Physiol. Heart. Circ. Physiol. 2007, 293(2). H1154-63.
11. Giani J.F., et al. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am. J. Physiol. Endocrinol. Metab. 2009, 296(2). E262-71.
12. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 2008, 32(Suppl. 4):S7-S12.
13. Hashimoto T., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012, 487(7408):477-481.
14. Henriksen E.J. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293(3). R974-80.
15. Kamata H., et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120(5):649-661.
16. Liao J., et al. Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 1998, 273(42):27320-27324.
17. Liu C., et al. Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 2012, 49(4):291-299.
18. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129(7):1261-1274.
19. Munoz M.C., et al. The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul. Pept. 2012, 177(1-3):1-11.
20. Nakatani Y., et al. Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 2004, 279(44):45803-45809.
21. Niu M.J., et al. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008, 34(1-3):56-61.
22. Paizis G., et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005, 54(12):1790-1796.
23. Perkins J.M., Davis S.N. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15(2):147-152.
24. Rao R.H. Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats. Am. J. Hypertens. 1994, 7(7 Pt 1):655-660.
25. Richey J.M., et al. Angiotensin II induces insulin resistance independent of changes in interstitial insulin. Am. J. Physiol. 1999, 277(5 Pt 1). E920-6.
26. Santos S.H., et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008, 57(2):340-347.
27. Santos S.H., et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler. Thromb. Vasc. Biol. 2010, 30(5):953-961.
28. Santos S.H., et al. Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats. J. Mol. Med. (Berl.) 2014, 92(3):255-265.
29. Sarzani R., et al. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J. Hypertens. 2008, 26(5):831-843.
30. Taniguchi C.M., Ueki K., Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 2005, 115(3):718-727.
31. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7(2):85-96.
32. Tham D.M., et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol. Genomics 2002, 11(1):21-30.
33. Tikellis C., et al. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 2004, 53(4):989-997.
34. Wei Y., et al. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J. Biol. Chem. 2006, 281(46):35137-35146.
35. Wu M., et al. Arachidonic acid can significantly prevent early insulin resistance induced by a high-fat diet. Ann. Nutr. Metab. 2007, 51(3):270-276.
36. Yang J.K., et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010, 47(3):193-199.
37. Yuan L., et al. Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet. Acta Diabetol 2010.